tiprankstipranks
Advertisement
Advertisement

KPRX Stock Latest News

Kiora Showcases Promising Preclinical Epilepsy Data for KIO-300
Company AnnouncementsKiora Showcases Promising Preclinical Epilepsy Data for KIO-300
16d ago
8K
KPRX
Kiora Pharmaceuticals Shareholders Approve Expanded Equity Incentive Plan
PremiumCompany Announcements
Kiora Pharmaceuticals Shareholders Approve Expanded Equity Incentive Plan
23d ago
8K
KPRX
Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders
PremiumThe Fly
Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders
2M ago
KPRX
KPRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KPRX Earnings this Week: How Will it Perform?
2M ago
KPRX
Strategic Financing and Differentiated KIO‑301 Pipeline Underpin Buy Rating on Kiora Pharmaceuticals (KPRX)
PremiumRatings
Strategic Financing and Differentiated KIO‑301 Pipeline Underpin Buy Rating on Kiora Pharmaceuticals (KPRX)
3M ago
KPRX
Kiora Pharmaceuticals Announces $5 Million Private Placement Financing
PremiumCompany AnnouncementsKiora Pharmaceuticals Announces $5 Million Private Placement Financing
3M ago
8K
KPRX
Kiora Pharmaceuticals Announces Chief Development Officer Resignation
Premium
Company Announcements
Kiora Pharmaceuticals Announces Chief Development Officer Resignation
3M ago
8K
KPRX
Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
Premium
Ratings
Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
4M ago
KPRX
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
PremiumRatings
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
8M ago
KPRX
Kiora Pharmaceuticals Reports Improved Financial Performance
PremiumCompany Announcements
Kiora Pharmaceuticals Reports Improved Financial Performance
8M ago
KPRX
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
8M ago
KPRX
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
8M ago
KPRX
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
PremiumCompany AnnouncementsKiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
8M ago
KPRX
Kiora Pharmaceuticals files $100M mixed securities shelf
Premium
The Fly
Kiora Pharmaceuticals files $100M mixed securities shelf
10M ago
KPRX
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
Premium
Company Announcements
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
11M ago
8K
KPRX
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
PremiumRatings
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
11M ago
KPRX
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
11M ago
KPRX
Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
PremiumRatings
Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
12M ago
KPRX
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
PremiumThe Fly
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
12M ago
KPRX
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors
PremiumCompany AnnouncementsKiora Pharmaceuticals Holds Annual Meeting, Elects Directors
1y ago
8K
KPRX
Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating
Premium
Ratings
Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating
1y ago
KPRX
Kiora Pharmaceuticals Secures Exclusive Option Agreement with Senju
Premium
Company Announcements
Kiora Pharmaceuticals Secures Exclusive Option Agreement with Senju
1y ago
8K
KPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >